LabelsCoin

LabelsCoin

ICO Ended
10,136 Views
LabelsCoin is a single-source copyright exchange platform based on blockchain technology with associated suite of services. Combined, these facilitate the transparency of copyrights and the exchange of associated royalties – allowing for a fair and transparent retribution to creators of music.
6.2
TOTAL SCORE
6.9
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 31 Oct 2018 - 31 Dec 2018
Country: Liechtenstein
Token info
Ticker: LBSC
Platform: Ethereum
Token Type: ERC-20
Available for sale: 22,200,000 LBSC (74%)
Financial
Raised $ 1,931,000
ICO Price: 1 LBSC = 0.00015 BTC
Accepting: ETH, BTC
Soft cap: 5000000 USD
Hard cap: 10000000 USD
November 2017
End of market research, white paper 0.1 version, legal advice, build a team.<br />
March 2018
LabelsCoin website and LBSC token creation, update white paper 0.2.<br />
April 2018
Patent the device and first meeting with Financial Market Authority of Liechtenstein, update white paper 0.3.<br />
June 2018
Genesis of LabelsCoin blockchain: genesis block creation, update white paper 0.4;<br /> <br /> Development of LabelsCoin blockchain, meet up conference Montreux Palace (Switzerland) press conference in Venafro, Italy.
July 2018
Legal advice of LBSC token, LabelsCoin officially International Trademark.<br />
August 2018
Second meeting with Financial Market Authority of Liechtenstein, incorporation of KYC in our website, development of blockchain, meet up with Swiss Cyber Security in Geneva, Switzerland.
September 2018
PRE-ICO: 33.4% of the token will be on pre-sale to determine the price of the ICO.<br />
November 2018
INITIAL COIN OFFERING, the 40% of tokens will be distributed.<br />
December 2018
Ongoing ICO.<br />
January 2019
Finalization of the blockchain services.
February 2019
Device production.<br />
June 2019
Go-live with blockchain services - Marketing campaign.<br />
Screenshots taken on 1 Dec 2018
Serena Spada
FOUNDER - CEO - INVENTOR
Participates in a number of projects
Bruno De Angelis
Artistic manager
Participates in a number of projects
Gregory Krieger
Chief Communication Officer
Participates in a number of projects
Anthony Fasano
Developper
Participates in a number of projects
Benoit Perret
IT Security Expert
Participates in a number of projects
Guido Varesano
Graphic designer
Participates in a number of projects
Jur. Frank Zindel
Legal advisor
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
TruePlay
TruePlay is a B2B platform with a complex of software solutions for online gambling business. TruePlay is not a gambling-provider, casino operator or casino owner. TruePlay allows only licensed gambling companies to access to their software (Software-as-a-service). The team are aimed at developing online gambling and making it as legal and transparent as possible from any point of view, TruePlay team has strong partners and has more than 10 years’ experience in the gambling industry.Join TruePlay and take part in the development of the gambling industry.
Upcoming
Nordcoin Mining
Cryptocurrencies, smart contracts and other blockchain technologies are experiencing a rapid surge in popularity. With a major share of the blockchain infrastructure today dependent on consensus protocols based on proof-of-work (PoW), an efficient and intelligent crypto-mining operation is well positioned to take advantage of the ongoing expansion. NordCoin Mining OÜ is based in the IT-friendly Estonia with operations foreseen across the Nordics. The Mobile Mining Container (MMC) technology developed by NordCoin is a self-sufficientself-contained, remote controlled crypto-mining solution designed to overcome the three most significant variables affecting the profitability of crypto-mining: effective hash rate, cost of energy, and cost of space. In total, 30 MMC's will be activated, with an estimated net profit of $45,000 worth of crypto per month per container.
Upcoming
RAVELOUS
Ravelous is the crypto ecommerce marketplace that lets users sell their stuff online for crypto. Sellers can accept many types of payments from buyers, and withdraw your balance in the token of their choosing. Buyers who do not have the currency the sellers prefer can exchange their coins for RAVE tokens which used for payment. The RAVE tokens can also be traded for other coins, and will have a value backed by the crypto-marketplace and the RAVE treasury that will increase over time as the treasury grows in value.
Upcoming
Gym Rewards
The GYM rewards app rewards you for exercising at the GYM by introducing Proof of Exercice to the blockchain. The more you exercise at the GYM, the more GYM Coins you will earn. GYM Coins are redeemable at your local participating gyms and will be tradable at participating cryptocurrency exchanges.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.